Testosterone Mind Map
Testosterone supplement · Facebook · 90 days

Hit a $90 CPA, then scale everything that holds it.

Start from what's already working, find what customers want that nobody is saying, and build better versions of the best ads. Fifteen new ads a week. One number decides what lives: a purchase CPA of $90 or better.

Within a few weeks, 10–13 of each week's 15 are variants of controls and 2–5 come from the bench. Scale controls, then run the bench.

1Research: what's working and what's missing

The Ad Library shows no spend, so the evidence is behaviour. An ad still live after six months is one somebody keeps paying for. On TikTok, each video's own 30-day sales. Every ad in the category was broken down and grouped by the idea it runs on.

1,671ads broken down and grouped by idea
256advertisers
678TikTok Shop videos, with sales estimates
230,014Reddit comments read, every one

Go deeper: every ad we pulled · formats · advertisers · TikTok · what men say · missing angles

The best ads: still running after six months

TikTok: the videos that sell

2The missing angles

I put what men say in 230,014 comments against what all 1,556 on-topic ads actually say. What's missing does two jobs.

What the comparison showsWhat we make
A strong control leaves an objection unansweredA variant that adds the answer. Bloodwork proof inside the honest review. Balanced minerals, not megadoses, inside the benefit static.
A motivation men keep raising is barely in the adsA new concept for the moonshot pool. No ashwagandha flatness. The walking wallet. The new dad running on no sleep. Lifting into your 50s without getting hurt.

A theme becomes a test only when our product can credibly answer it. All 17 missing angles, with the men's words and the nearest existing ads →

3The top 15: our presumed controls

These are the 15 competitor ads that show what's working. They start as our presumed controls. We make our own version of each, aiming to be 10% better by working in the missing angles from the research.

Five picks (marked) depend on a real bundle, bonus, ingredient or demonstration. If our product doesn't have it, the slot goes to the bench.

An example: Day 27, with real lab results

The competitor ad: Day 27 of taking this

Their ad, as it runs

Our version: a different man and an unbranded bottle, with (Real lab results included) under Day 27 of taking this

Our version (mock-up)

The control

"Day 27 of taking this"

HappySupp. A man on his couch mocking the hype and giving an honest account. 591 days and still running; the same script is TikTok's most-viewed video at 39.1M.

What men keep saying
"Without the blood work to back this up, then this is all in your head." r/trt
The change

Our own actor and product, same setup and script. Under "Day 27 of taking this": (Real lab results included). He still says he can feel the difference, and now he shows it: "I can feel it in my body, and I can see it in my bloodwork," with the lab screenshots on screen. No "my testosterone went from X to Y" claim, which Meta won't take.

What the result makes me do
  • ≤ $90: it's a control. It keeps running and scaling, and its next version is an optimization.
  • Promising: the lab-proof angle gets a substantially different ad.
  • Kill pile: it comes off, and the slot goes to the bench.
Every ad we pulled. All 1,193 Facebook ads and 714 TikTok, Instagram and Top Ads videos, each with its copy and full breakdown. See every ad →

4The KPI: $90 CPA or better

We choose one success criterion. Here the client gave it: a $90 cost per purchase. Every other number gives us opportunities to test our way to it, but a strong hook rate on a failing ad is a failing ad.

Decides survival
Purchase CPA

At or under $90, the ad is a control. Above it, the ad hasn't done the job.

Every other number
Opportunities to test

Hook rate, hold rate, click-through and conversion rate tell us where an ad is close and what to try next. They never keep an ad alive.

For example: an ad with a huge hook rate and no sales doesn't work, and it comes off. But it's told us that opening stops men. So a later ad opens the same way and puts something completely different behind it. That's a new ad, not a variant of the one that failed.

5Three piles

An ad earns continued spend. An idea earns another production slot. They're separate decisions.

Controls
≤ $90

It keeps running as long as it holds $90, and spend rises while it does. Its challenger is an extra shot at a better ad, not a replacement. Its next creative is an optimization: a stronger opening, clearer proof, better pacing.

Promising
$91–$135

Above target, but the angle is worth playing with. We don't optimize this ad. We take the angle and make something substantially different with it: what would it look like as a TED-talk ad? The original ad usually stops after its first week, though a judgment call can extend it. For example, an ad that opened at $125 and ended its first five days at $92 can earn five more while Facebook finds its audience.

Kill pile
> $135

Or no real improvement. The ad comes off and its angle leaves the current queue. That doesn't mean the angle can never work. We have stronger candidates waiting, so the slot goes to the bench.

6The week

Friday to Friday. Weekends are where consumer performance happens, so every cohort launches Friday with its weekend spend set. Week one is the exception: the first 15 go live on a Monday.

Friday

Launch the new cohort. Set spend going into the weekend.

Monday

Make sure everything is delivering. Let it run; only something atrocious gets touched.

Wednesday

Read Friday to Wednesday against the KPI. Sort into the three piles and decide next week's creative.

Thursday

Build it. Friday, launch it.

7Scale controls, then run the bench

Failures fall away fast, and many go after week one. Controls accumulate, because the limit is fifteen new ads a week, not the number of ads running. Within a few weeks most of production goes into variants of controls. The rest goes to the bench: the remaining control families, the missing angles and the moonshots.

Variants of controlsNew ads on promising anglesFrom the bench and moonshots

An illustrative mix; each Wednesday's read sets the real one.

On the bench, on purpose. Three long-running families aren't in week one. The "hung like a horse" size innuendo (426 days) and the female-partner confessional (377 days) put a supplement account at risk with Meta. The "Top 3 supplements" advertorial (347 days) needs a landing page we don't have yet.
Browse the full inventory: every group, every ad

Click a group to see each idea in it and every ad, with its control outlined. Click an ad for its breakdown.

8Moonshots

The bench holds the presumed controls that didn't make the first run. But the research also turned up new ideas: conversations men are having that no ad in the category is part of. We mix these in as we go, as we find which of the bench's controls aren't playing well.

The unseen provider

"Stop being the walking wallet."

"What I feel is I'm the unseen glue that keeps my family together... No one thanks me for anything it's just expected." 6,206 upvotes, r/AskMen
6,206 men upvoted it. Ads show tired dads getting energy for chores; none touches being seen.
Ashwagandha flatness

"Is your T booster leaving you hollow and empty?"

"It slowly sucked my emotions from me and left me feeling hollow and empty." r/Supplements
Hundreds of ads include ashwagandha and 77 sell KSM-66 by name. Not one mentions what men say it does to them. Only if our formula has none.
The fear behind TRT

"Are you shriveling your nuts?"

"Does it shrink the balls badly that's the one thing scaring me from starting" r/trt
Men weighing TRT fear shrinkage and a lifelong commitment. The ads compete with each other, not with the needle.

All 17 missing angles from the research, with the men's words and the nearest existing ads →